15.10.2021 17:40

ARKAY vs. FMC: Which Stock Should Value Investors Buy Now?

Folgen
Werbung
Investors interested in Chemical - Diversified stocks are likely familiar with Arkema SA (ARKAY) and FMC (FMC). But which of these two stocks is more attractive to value investors? We'll need to take a closer look to find out.There are plenty of strategies for discovering value stocks, but we have found that pairing a strong Zacks Rank with an impressive grade in the Value category of our Style Scores system produces the best returns. The proven Zacks Rank puts an emphasis on earnings estimates and estimate revisions, while our Style Scores work to identify stocks with specific traits.Currently, Arkema SA has a Zacks Rank of #2 (Buy), while FMC has a Zacks Rank of #5 (Strong Sell). The Zacks Rank favors stocks that have recently seen positive revisions to their earnings estimates, so investors should rest assured that ARKAY has an improving earnings outlook. But this is just one piece of the puzzle for value investors.Value investors also try to analyze a wide range of traditional figures and metrics to help determine whether a company is undervalued at its current share price levels.The Value category of the Style Scores system identifies undervalued companies by looking at a number of key metrics. These include the long-favored P/E ratio, P/S ratio, earnings yield, cash flow per share, and a variety of other fundamentals that help us determine a company's fair value.ARKAY currently has a forward P/E ratio of 12.02, while FMC has a forward P/E of 13.53. We also note that ARKAY has a PEG ratio of 0.41. This popular metric is similar to the widely-known P/E ratio, with the difference being that the PEG ratio also takes into account the company's expected earnings growth rate. FMC currently has a PEG ratio of 1.23.Another notable valuation metric for ARKAY is its P/B ratio of 1.44. The P/B ratio is used to compare a stock's market value with its book value, which is defined as total assets minus total liabilities. For comparison, FMC has a P/B of 3.76.These metrics, and several others, help ARKAY earn a Value grade of A, while FMC has been given a Value grade of C.ARKAY has seen stronger estimate revision activity and sports more attractive valuation metrics than FMC, so it seems like value investors will conclude that ARKAY is the superior option right now.Infrastructure Stock Boom to Sweep AmericaA massive push to rebuild the crumbling U.S. infrastructure will soon be underway. It’s bipartisan, urgent, and inevitable. Trillions will be spent. Fortunes will be made.The only question is “Will you get into the right stocks early when their growth potential is greatest?”Zacks has released a Special Report to help you do just that, and today it’s free. Discover 7 special companies that look to gain the most from construction and repair to roads, bridges, and buildings, plus cargo hauling and energy transformation on an almost unimaginable scale.Download FREE: How to Profit from Trillions on Spending for Infrastructure >>Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report Arkema SA (ARKAY): Free Stock Analysis Report FMC Corporation (FMC): Free Stock Analysis Report To read this article on Zacks.com click here. Zacks Investment Research
Weiter zum vollständigen Artikel bei "Zacks"
Quelle: Zacks

Nachrichten zu Fresenius Medical Care AG & Co. KGaA (FMC) St.

  • Relevant
  • Alle
    2
  • vom Unternehmen
  • Peer Group
  • ?

Um Ihnen die Übersicht über die große Anzahl an Nachrichten, die jeden Tag für ein Unternehmen erscheinen, etwas zu erleichtern, haben wir den Nachrichtenfeed in folgende Kategorien aufgeteilt:

Relevant: Nachrichten von ausgesuchten Quellen, die sich im Speziellen mit diesem Unternehmen befassen

Alle: Alle Nachrichten, die dieses Unternehmen betreffen. Z.B. auch Marktberichte die außerdem auch andere Unternehmen betreffen

vom Unternehmen: Nachrichten und Adhoc-Meldungen, die vom Unternehmen selbst veröffentlicht werden

Peer Group: Nachrichten von Unternehmen, die zur Peer Group gehören

Analysen zu Fresenius Medical Care AG & Co. KGaA (FMC) St.

  • Alle
  • Buy
  • Hold
  • Sell
  • ?
01.12.2021Fresenius Medical Care BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
01.12.2021Fresenius Medical Care HoldDeutsche Bank AG
01.12.2021Fresenius Medical Care HoldJefferies & Company Inc.
17.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.
11.11.2021Fresenius Medical Care HoldJefferies & Company Inc.
01.12.2021Fresenius Medical Care BuyJoh. Berenberg, Gossler & Co. KG (Berenberg Bank)
05.11.2021Fresenius Medical Care KaufenDZ BANK
05.11.2021Fresenius Medical Care KaufenNorddeutsche Landesbank (Nord/LB)
05.11.2021Fresenius Medical Care BuyUBS AG
04.11.2021Fresenius Medical Care BuyGoldman Sachs Group Inc.
01.12.2021Fresenius Medical Care HoldDeutsche Bank AG
01.12.2021Fresenius Medical Care HoldJefferies & Company Inc.
11.11.2021Fresenius Medical Care HoldJefferies & Company Inc.
03.11.2021Fresenius Medical Care NeutralCredit Suisse Group
02.11.2021Fresenius Medical Care HoldDeutsche Bank AG
17.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.
09.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.
03.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.
02.11.2021Fresenius Medical Care UnderperformJefferies & Company Inc.
02.11.2021Fresenius Medical Care UnderweightJP Morgan Chase & Co.

Um die Übersicht zu verbessern, haben Sie die Möglichkeit, die Analysen für Fresenius Medical Care AG & Co. KGaA (FMC) St. nach folgenden Kriterien zu filtern.

Alle: Alle Empfehlungen

Buy: Kaufempfehlungen wie z.B. "kaufen" oder "buy"

Hold: Halten-Empfehlungen wie z.B. "halten" oder "neutral"

Sell: Verkaufsempfehlungn wie z.B. "verkaufen" oder "reduce"
mehr Analysen
Werbung
Werbung
Werbung
Werbung
Börse Stuttgart Anlegerclub
Werbung

Heute im Fokus

DAX kräftig im Plus -- US-Börsen grün -- Behörde verbietet Delivery Hero Saudi-Arabien-Zukauf -- Saint-Gobain will GCP Applied Technologies übernehmen -- Tesla, Telekom, Airbus, Deutsche Bank im Fokus

AstraZeneca erwägt womöglich Börsengang der Impfstoffsparte. Bewegung im Ringen um italienischen Telekomkonzern TIM - Gegenwind für KKR. Allianz erwirbt Anteil an Offshore-Windpark von BASF. Aufregung nach spektakulärem Bundesliga-Gipfel zwischen FC Bayern und BVB. Deutsche Wohnen kommt für zooplus in MDAX - Auch Änderungen in SDAX und TecDAX.

Umfrage

Wie hat sich Ihr Wertpapierdepot seit Jahresbeginn entwickelt?

finanzen.net zero
finanzen.net zero

Oskar

ETF-Sparplan

Oskar ist der einfache und intelligente ETF-Sparplan. Er übernimmt die ETF-Auswahl, ist steuersmart, transparent und kostengünstig.
Zur klassischen Ansicht wechseln